OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic
John H. Krystal, Chadi G. Abdallah, Lynette A. Averill, et al.
Current Psychiatry Reports (2017) Vol. 19, Iss. 10
Open Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

Involvement of Nuclear Factor-κB in Inflammation and Neuronal Plasticity Associated with Post-Traumatic Stress Disorder
Sudhiranjan Gupta, Rakeshwar S. Guleria
Cells (2022) Vol. 11, Iss. 13, pp. 2034-2034
Open Access | Times Cited: 25

Psilocybin for Trauma-Related Disorders
Amanda Khan, Ellen Bradley, Aoife O’Donovan, et al.
Current topics in behavioral neurosciences (2022), pp. 319-332
Closed Access | Times Cited: 23

Biological Mechanisms of Stress Resilience
Saren H. Seeley, Sarah Boukezzi, Jonathan DePierro, et al.
Oxford University Press eBooks (2025), pp. 553-570
Closed Access

Ketamine: New Uses for an Old Drug?
Nelson F. Jones, Elizabeth A. M. Frost
Topics in Pain Management (2025) Vol. 40, Iss. 8, pp. 1-6
Closed Access

Neuroglia in anxiety disorders
Robin Bonomi, Robert H. Pietrzak, Kelly Cosgrove
Handbook of clinical neurology (2025), pp. 335-346
Closed Access

The failing cascade: Comorbid post traumatic stress- and opioid use disorders
Igor Elman, David Borsook
Neuroscience & Biobehavioral Reviews (2019) Vol. 103, pp. 374-383
Closed Access | Times Cited: 41

Nerve growth factor against PTSD symptoms: Preventing the impaired hippocampal cytoarchitectures
Dayun Feng, Baolin Guo, Gaohua Liu, et al.
Progress in Neurobiology (2019) Vol. 184, pp. 101721-101721
Closed Access | Times Cited: 35

Mild traumatic brain injury impacts associations between limbic system microstructure and post-traumatic stress disorder symptomatology
Valerie J. Sydnor, Sylvain Bouix, Ofer Pasternak, et al.
NeuroImage Clinical (2020) Vol. 26, pp. 102190-102190
Open Access | Times Cited: 33

Encoding, Consolidation, and Renormalization in Depression: Synaptic Homeostasis, Plasticity, and Sleep Integrate Rapid Antidepressant Effects
Tomi Rantamäki, Samuel Kohtala
Pharmacological Reviews (2020) Vol. 72, Iss. 2, pp. 439-465
Open Access | Times Cited: 33

Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence
Agnes Norbury, Sarah Rutter, Abigail B. Collins, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 13, pp. 2266-2277
Open Access | Times Cited: 31

Toward staging differentiation for posttraumatic stress disorder treatment
Mirjam J. Nijdam, Eric Vermetten, Alexander C. McFarlane
Acta Psychiatrica Scandinavica (2022) Vol. 147, Iss. 1, pp. 65-80
Open Access | Times Cited: 20

Maternal deprivation causes CaMKII downregulation and modulates glutamate, norepinephrine and serotonin in limbic brain areas in a rat model of single prolonged stress
Đorđe Đorović, Vesna Lazarevic, Jovana Aranđelović, et al.
Journal of Affective Disorders (2024) Vol. 349, pp. 286-296
Open Access | Times Cited: 4

So how special is special K? A systematic review and meta-analysis of ketamine for PTSD RCTs
Nicholas C. Borgogna, Tyler Owen, Jacob Vaughn, et al.
European journal of psychotraumatology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

Molecular and Cellular Effects of Traumatic Stress: Implications for PTSD
Matthew J. Girgenti, Brendan Hare, Sriparna Ghosal, et al.
Current Psychiatry Reports (2017) Vol. 19, Iss. 11
Open Access | Times Cited: 37

Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies
Jonathan DePierro, Lauren Lepow, Adriana Feder, et al.
Biological Psychiatry (2019) Vol. 86, Iss. 6, pp. 454-463
Open Access | Times Cited: 34

Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial
Chadi G. Abdallah, John D. Roache, Lynnette A. Averill, et al.
Contemporary Clinical Trials (2019) Vol. 81, pp. 11-18
Open Access | Times Cited: 30

mTORC1 Signaling Pathway Mediates Chronic Stress-Induced Synapse Loss in the Hippocampus
Yufei Luo, Xiaoxia Ye, Ying-Zhao Fang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26

(2R,6R)-hydroxynorketamine acts through GluA1-induced synaptic plasticity to alleviate PTSD-like effects in rat models
Yu Li, Yalin Du, Chen Wang, et al.
Neurobiology of Stress (2022) Vol. 21, pp. 100503-100503
Open Access | Times Cited: 16

Novel Pharmacological Targets of Post-Traumatic Stress Disorders
Donatella Marazziti, Claudia Carmassi, Gabriele Cappellato, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1731-1731
Open Access | Times Cited: 10

BLA DBS improves anxiety and fear by correcting weakened synaptic transmission from BLA to adBNST and CeL in a mouse model of foot shock
Yan Gao, Dawen Gao, Hui Zhang, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113766-113766
Open Access | Times Cited: 3

Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine
Viviana D. Evans, Alejandro Arenas, Kenneth Shinozuka, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 2, pp. e155-e177
Closed Access | Times Cited: 3

Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression
Ruth Asch, Chadi G. Abdallah, Richard E. Carson, et al.
Neuropsychopharmacology (2024) Vol. 50, Iss. 1, pp. 153-163
Closed Access | Times Cited: 3

Scroll to top